Skip to main content
Skip to section navigation
Skip to footer
Home
About Us
Overview
Leadership
Board of Directors
Scientific Advisors (DMD)
Our Science
CAP-1002 (Cell Therapy)
Exosomes Technology
Publications
Strategic Partnerships
Pipeline
Pipeline
Duchenne Muscular Dystrophy Overview
Clinical Trials
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Careers
Contact
IR Calendar
Investors
Investors
Overview
News & Events
Overview
Press Releases
In the News
IR Calendar
Presentations
Email Alerts
Company Info
Overview
Leadership
Contacts
FAQ
Financial Info
Overview
Financial Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Latest Proxy Statement and Annual Report
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity
KOL Call on Why Exosomes are Uniquely Suited for Vaccine Development
Mar 26, 2020
Presentation
PDF
Email Alerts
Company Profile
Contacts
RSS News Feed